May 17, 2023Insight Author
Cecelia Byers, Pharm.D.

Cecelia brings clinical expertise to Surescripts as a Specialty Clinical Product Advisor. As a pharmacist, Cecelia has a passion for patient care and uses that…

May 17, 2023Insight Author
Bonnie Radintz

Bonnie Radintz leads the Integration, Customer Success and Education Services teams at Surescripts. She has spent more than 20 years streamlining and…

May 17, 2023Insight Author
Bobby Davis

Bobby Davis is a Vice President of Key Accounts for Surescripts, with a primary focus of directly managing the relationships of strategic accounts within the…

May 17, 2023Insight Author
Ashley Fifield

Ashley Fifield has worked in the healthcare industry for more than 10 years, and has primarily focused on health information technology in hospitals and…

May 17, 2023Insight Author
Andrew Mellin, MD

Dr. Andrew Mellin is the Chief Medical Information Officer at Surescripts. Since joining in 2018, his tenure is marked by advancing strategic healthcare IT…

May 17, 2023Insight Author
Judy Hatchett

Judy Hatchett sets the vision, develops plans and oversees execution of Surescripts’ Enterprise Information and Physical Security, Business Continuity and Risk…

May 17, 2023Insight Author
Patricia Krause

Tricia is responsible for product planning and execution for Surescripts E-Prescribing. She has worked in healthcare for nearly 20 years, having spent time as…

May 17, 2023Insight Author
Andrea Douglas

Andrea Douglas is an expert in pharmaceutical market access and reimbursement, including value- based contracting. Andrea’s background in public policy and…

May 16, 2023Insights
Recipe for Affordability: One Dash Biosimilar, One Pinch Health IT

Biosimilars have come to market. The FDA has given the green light to 40 biosimilars as of December 2022, and there are more to come. This could mean better…